News out! Look at the grades!CHICAGO, IL--(Marketwire - 01/26/10) - Tara Minerals Corp. (OTC.BB:TARM - News) (Berlin:6T3 - News), a subsidiary of Tara Gold Resources Corp. (Pinksheets:TRGD - News) (Frankfurt:T8N - News), is pleased to announce additional results from the new Silver, Zinc, and Lead vein discovery at its flagship Don Roman mine in Mexico. Channel samples across an additional 2 meters of the exposed portion of the vein returned 919 grams per tonne Silver, 29.65% Zinc, and 14.1% Lead.
To date, more than 8 meters of the vein width has been exposed (see news release dated January 21, 2010) with work ongoing to identify the hanging wall and footwall edges. Tara Minerals continues to drift towards the new vein structure from existing mine tunnels with the goal of adding this material into the current mining plan.
Mr. Francis Biscan Jr., President of Tara Minerals Corp., stated, "Results to date are extremely encouraging and efforts to identify the hanging wall and footwall edges are continuing. Results of these ongoing efforts will be announced at the appropriate time."
About Tara Minerals Corp.
Tara Minerals Corp. is generating cash from the sale of Silver, Zinc, and Lead concentrate from its producing Don Roman mine and mill, located in Choix, Mexico. Management is focused on creating long-term shareholder value as this capital is deployed to increase throughput, enhance resources, further outline new discoveries/targets, and acquire additional strategic assets. Tara's strength in recognizing value early and strategy of reducing risk through a foundation of cash flow, positions it for low-risk value creation.
Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995: The statements contained herein which are not historical are forward-looking statements that are subject to risks and uncertainties that could cause actual results to differ materially from those expressed in the forward-looking statements, including, but not limited to, certain delays beyond the company's control with respect to market acceptance of new technologies or products, delays in testing and evaluation of products, and other risks detailed from time to time in the Company's filings with the Securities and Exchange Commission.